Volume 66, Issue 10

Search all Cancer Immunology, Immunotherapy articles

October 2017

Cancer Immunology, Immunotherapy

Filter by

Volume:

Sort by

Date published:

New to old Old to new

13 articles in this issue

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Omid Hamid
Brianna Hoffner
Richard D. Carvajal
Review Open access 15 July 2017 Pages: 1249 - 1264
Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case–control study in Northern China
Sheng Han
Jian Deng
Anhua Wu
Original Article 18 May 2017 Pages: 1265 - 1273
CD45RA⁻Foxp3^high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma
Fumie Ihara
Daiju Sakurai
Yoshitaka Okamoto
Original Article 27 May 2017 Pages: 1275 - 1285
Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro
Sarah J. Storr
Sabreena Safuan
Stewart G. Martin
Original Article Open access 27 May 2017 Pages: 1287 - 1294
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy
Simone Battella
M. Christina Cox
Gabriella Palmieri
Original Article 29 May 2017 Pages: 1295 - 1306
In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells
Yildian Díaz-Rodríguez
Paulo Cordeiro
Michel Duval
Original Article Open access 29 May 2017 Pages: 1307 - 1320
TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model
Fang Huang
Jiangbo Wan
Liyuan Ma
Original Article 10 June 2017 Pages: 1321 - 1331
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists
Tanja Lövgren
Dhifaf Sarhan
Rolf Kiessling
Original Article Open access 10 June 2017 Pages: 1333 - 1344
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer
Guru Sonpavde
John D. McMannis
Kevin M. Slawin
Original Article 12 June 2017 Pages: 1345 - 1357
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
Sapna P. Patel
Dae Won Kim
Agop Y. Bedikian
Original Article 13 June 2017 Pages: 1359 - 1366
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions
Feng Xu
Alexander Sunderland
Yuwen Zhu
Original Article 16 June 2017 Pages: 1367 - 1375
Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab
Markus V. Heppt
Ilana Goldscheider
Carola Berking
Letter to the Editors 11 May 2017 Pages: 1377 - 1378
A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer
Weili Wang
Ping Liao
Yijing He
Letter to the Editors 24 May 2017 Pages: 1379 - 1381

Volume 66, Issue 10

Search

Navigation